“Experimental Alzheimer's drug shows promise”
A clinical trial is now underway to test a new drug that shows promise for slowing the relentless progression of memory loss and mental decline in Alzheimer's patients. The drug is called T-817MA and it's designed to protect nerve cells in the brain. Learn more

Press Release
Mount Sinai Launches AI Small Molecule Drug Discovery Center
Apr 02, 2025 View All Press Releases